AI, NVIDIA and supercomputer
Digest more
Eli Lilly shares surged after strong third-quarter results and a raised annual forecast, powered by booming demand for its ...
Eli Lilly reported higher profit and raised its outlook on surging demand for its weight-loss drugs, sending its shares ...
Nvidia’s shares jumped nearly 11% over the past month, adding about $500 billion in market value as it became the first ...
Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently provided insights on. Cramer highlighted it as the ...
Under the agreement, Lilly will gain control of Adverum’s lead product candidate, Ixo-vec, a Phase 3 gene therapy designed to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback